<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32452414</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN><JournalIssue CitedMedium="Internet"><Volume>546</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus.</ArticleTitle><Pagination><StartPage>20</StartPage><EndPage>24</EndPage><MedlinePgn>20-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2020.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0042-6822(20)30062-3</ELocationID><Abstract><AbstractText>Coxsackieviruses primarily infect the gastrointestinal tract of humans, but they can disseminate systemically and cause severe disease. Using antibiotic treatment regimens to deplete intestinal microbes in mice, several groups have shown that bacteria promote oral infection with a variety of enteric viruses. However, it is unknown whether antibiotics have microbiota-independent antiviral effects for enteric viruses or whether antibiotics influence extra-intestinal, systemic infection. Here, we examined the effects of antibiotics on systemic enteric virus infection by performing intraperitoneal injections of either coxsackievirus B3 (CVB3) or poliovirus followed by quantification of viral titers. We found that antibiotic treatment reduced systemic infection for both viruses. Interestingly, antibiotics reduced CVB3 titers in germ-free mice, suggesting that antibiotic treatment alters CVB3 infection through a microbiota-independent mechanism. Overall, these data provide further evidence that antibiotics can have noncanonical effects on viral infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woods Acevedo</LastName><ForeName>Mikal A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeiffer</LastName><ForeName>Julie K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Julie.Pfeiffer@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI074668</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI074668</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007520</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Coxsackievirus</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">Poliovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32452414</ArticleId><ArticleId IdType="mid">NIHMS1584907</ArticleId><ArticleId IdType="pmc">PMC7253499</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2020.04.001</ArticleId><ArticleId IdType="pii">S0042-6822(20)30062-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen P, Tao Z, Song Y, Liu G, Wang H, Liu Y, Song L, Li Y, Lin X, Cui N, Xu A. 2013. A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009. J Med Virol 85:483&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23212939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE. 2006. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 19:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. 2000. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">10935991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS. 2002. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136885</ArticleId><ArticleId IdType="pubmed">12414951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Drescher KM. 2007. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann N Y Acad Sci 1103:143&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">17376828</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Woods Acevedo MA, McCune BT, Pfeiffer JK. 2019. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice. J Virol 93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6854509</ArticleId><ArticleId IdType="pubmed">31511379</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Wang Y, Pfeiffer JK. 2017. Sex-Dependent Intestinal Replication of an Enteric Virus. J Virol 91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5355612</ArticleId><ArticleId IdType="pubmed">28100612</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt CJ, Trousdale MD, LaBadie DR, Paque RE, Nealon T. 1979. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol 3:207&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">225441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Rose NR. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41:118&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. 1986. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol 136:1846&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">3005402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, Dermody TS, Pfeiffer JK. 2011. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334:249&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222156</ArticleId><ArticleId IdType="pubmed">21998395</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, Diamond MS, Ivanova Y, Artyomov M, Virgin HW. 2015. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347:266&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409937</ArticleId><ArticleId IdType="pubmed">25431490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV, Golovkina TV. 2011. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334:245&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519937</ArticleId><ArticleId IdType="pubmed">21998394</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. 2014. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis 210:171&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4399425</ArticleId><ArticleId IdType="pubmed">24436449</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods Acevedo MA, Erickson AK, Pfeiffer JK. 2019. The Antibiotic Neomycin Enhances Coxsackievirus Plaque Formation. mSphere 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382971</ArticleId><ArticleId IdType="pubmed">30787120</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgun A, Dzutsev A, Dong X, Greer Rl, Sexton DJ, Ravel J, Schuster M, Hsiao W, Matzinger P, Shulzhenko N. 2015. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 64:1732&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5166700</ArticleId><ArticleId IdType="pubmed">25614621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JH, Bhargava P, McCloskey D, Mao N, Palsson BO, Collins JJ. 2017. Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function. Cell Host Microbe 22:757&#x2013;765 e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5730482</ArticleId><ArticleId IdType="pubmed">29199098</ArticleId></ArticleIdList></Reference><Reference><Citation>Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, Jovaisaite V, Frochaux MV, Quiros PM, Deplancke B, Houtkooper RH, Auwerx J. 2015. Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research. Cell Rep 10:1681&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565776</ArticleId><ArticleId IdType="pubmed">25772356</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinath S, Kim MV, Rakib T, Wong PW, van Zandt M, Barry NA, Kaisho T, Goodman AL, Iwasaki A. 2018. Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner. Nat Microbiol 3:611&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918160</ArticleId><ArticleId IdType="pubmed">29632368</ArticleId></ArticleIdList></Reference><Reference><Citation>Spees AM, Wangdi T, Lopez CA, Kingsbury DD, Xavier MN, Winter SE, Tsolis RM, Baumler AJ. 2013. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. mBio 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3705454</ArticleId><ArticleId IdType="pubmed">23820397</ArticleId></ArticleIdList></Reference><Reference><Citation>Thackray LB, Handley SA, Gorman MJ, Poddar S, Bagadia P, Briseno CG, Theisen DJ, Tan Q, Hykes BL Jr., Lin H, Lucas TM, Desai C, Gordon JI, Murphy KM, Virgin HW, Diamond MS. 2018. Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections. Cell Rep 22:3440&#x2013;3453 e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5908250</ArticleId><ArticleId IdType="pubmed">29590614</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunicke H, Pushendorf B, Werchau H. 1976. Mechanism of action of distamycin A and other antibiotics with antiviral activity. Rev Physiol Biochem Pharmacol 75:69&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">59940</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng S, Meng X, Huang Q, Lei N, Zeng L, Jiang X, Guo X. 2019. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo. Int J Antimicrob Agents 53:362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">30599241</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawage SS, Tiwari PM, Pillai S, Dennis VA, Singh SR. 2019. Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection. Viruses 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723987</ArticleId><ArticleId IdType="pubmed">31405261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy EA, King KY, Baldridge MT. 2018. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front Physiol 9:1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220354</ArticleId><ArticleId IdType="pubmed">30429801</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, Andrusaite A, Andersen P, Lawson M, Alcon-Giner C, Leclaire C, Caim S, Le Gall G, Shaw T, Connolly JPR, Roe AJ, Wessel H, Bravo-Blas A, Thomson CA, Kastele V, Wang P, Peterson DA, Bancroft A, Li X, Grencis R, Mowat AM, Hall LJ, Travis MA, Milling SWF, Mann ER. 2018. Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis. Sci Transl Med 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548564</ArticleId><ArticleId IdType="pubmed">30355800</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello VR, Baltimore D. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A 78:4887&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC320284</ArticleId><ArticleId IdType="pubmed">6272282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer JK, Kirkegaard K. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100:7289&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165868</ArticleId><ArticleId IdType="pubmed">12754380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>